Please use this identifier to cite or link to this item:
https://scholarhub.balamand.edu.lb/handle/uob/5750
Title: | Ovulation induction with gonadotropins | Authors: | Delbaere, Anne Bruyneel, Aude Papas, Ralph |
Affiliations: | Faculty of Medicine | Keywords: | Anovulatory disorder Assisted reproductive technologies (ART) Controlled ovarian hyperstimulation Follicle stimulating hormone (FSH) Gonadotropin Gonadotropin-releasing hormone (GnRH) Human chorionic gonadotropin (hCG) In vitro gertilization (IVF) Infertility Intra-uterine insemination (IUI) Luteinizing hormone (LH) Ovarian hyperstimulation syndrome (OHSS) Ovarian reserve Ovulation induction Timed-intercourse |
Issue Date: | 2018 | Part of: | Encyclopedia of Endocrine Diseases | Start page: | 570 | End page: | 580 | Abstract: | Gonadotropins have been available for clinical use for > 60 years for many conditions in the field of reproductive medicine. The article provides an overview of the pioneering work leading to the wide range of pharmaceutical gonadotropin preparations currently available. It underlines the major difference between ovulation induction intended to restore normal ovulation and promote monofollicular development in anovulatory patients and controlled ovarian hyperstimulation intended to induce a multi-follicular ovulation in infertile patients, often ovulatory, in order to increase their chance of conception. Different treatment regimens are addressed that are intended to avoid major side-effects, such as high-order multiple pregnancies and OHSS. |
URI: | https://scholarhub.balamand.edu.lb/handle/uob/5750 | ISBN: | 9780128122006 | DOI: | 10.1016/B978-0-12-801238-3.65169-3 | Type: | Book Chapter |
Appears in Collections: | Faculty of Medicine |
Show full item record
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.